Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nina Fluschnik

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
BMJ Case Reports|September 24, 2014
Fatal recurrence of fulminant giant cell myocarditis and recovery after initialisation of an alternative immunosuppressive regimeNina Fluschnik, Felicitas Escher, Stefan Blankenberg, et al.
World Journal of Cardiology|September 29, 2015
Challenging aspects of treatment strategies in heart failure with preserved ejection fraction: "Why did recent clinical trials fail?"Peter Moritz Becher, Nina Fluschnik, Stefan Blankenberg, et al.
Heartrhythm Case Reports|July 26, 2023
Transient dysfunction of leadless pacemaker system after cardioversionMoritz Nies, Nina Fluschnik, Tilman Würger, et al.
Expert Opinion on Medical Diagnostics|August 13, 2013
Diagnosing heart failure with preserved ejection fractionPeter Moritz Becher, Diana Lindner, Nina Fluschnik, et al.
World Journal of Clinical Cases|March 19, 2016
Fulminant isolated cardiac sarcoidosis with pericardial effusion and acute heart failure: Challenging aspects of diagnosis and treatmentNina Fluschnik, Gunnar Lund, Peter Moritz Becher, et al.
Plos One|March 15, 2018
Role of Toll-like receptors and interferon regulatory factors in different experimental heart failure models of diverse etiology: IRF7 as novel cardiovascular stress-inducible factorPeter Moritz Becher, Svenja Hinrichs, Nina Fluschnik, et al.
Plos One|May 18, 2018
Predictive value of long-term changes of growth differentiation factor-15 over a 27-year-period for heart failure and death due to coronary heart diseaseNina Fluschnik, Francisco Ojeda, Tanja Zeller, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|September 12, 2022
Temporal trends in incidence, patient characteristics, microbiology and in-hospital mortality in patients with infective endocarditis: a contemporary analysis of 86,469 cases between 2007 and 2019Peter Moritz Becher, Alina Goßling, Nina Fluschnik, et al.
Critical Care (London, England)|September 7, 2021
Seasonal trends of incidence and outcomes of cardiogenic shock : findings from a large, nationwide inpatients sample with 441,696 casesPeter Moritz Becher, Benedikt Schrage, Alina Goßling, et al.
Critical Care (London, England)|June 7, 2020
Procedural volume and outcomes in patients undergoing VA-ECMO supportPeter Moritz Becher, Alina Goßling, Benedikt Schrage, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
BMJ Case Reports|September 24, 2014
Fatal recurrence of fulminant giant cell myocarditis and recovery after initialisation of an alternative immunosuppressive regimeNina Fluschnik, Felicitas Escher, Stefan Blankenberg, et al.
World Journal of Cardiology|September 29, 2015
Challenging aspects of treatment strategies in heart failure with preserved ejection fraction: "Why did recent clinical trials fail?"Peter Moritz Becher, Nina Fluschnik, Stefan Blankenberg, et al.
Heartrhythm Case Reports|July 26, 2023
Transient dysfunction of leadless pacemaker system after cardioversionMoritz Nies, Nina Fluschnik, Tilman Würger, et al.
Expert Opinion on Medical Diagnostics|August 13, 2013
Diagnosing heart failure with preserved ejection fractionPeter Moritz Becher, Diana Lindner, Nina Fluschnik, et al.
World Journal of Clinical Cases|March 19, 2016
Fulminant isolated cardiac sarcoidosis with pericardial effusion and acute heart failure: Challenging aspects of diagnosis and treatmentNina Fluschnik, Gunnar Lund, Peter Moritz Becher, et al.
Plos One|March 15, 2018
Role of Toll-like receptors and interferon regulatory factors in different experimental heart failure models of diverse etiology: IRF7 as novel cardiovascular stress-inducible factorPeter Moritz Becher, Svenja Hinrichs, Nina Fluschnik, et al.
Plos One|May 18, 2018
Predictive value of long-term changes of growth differentiation factor-15 over a 27-year-period for heart failure and death due to coronary heart diseaseNina Fluschnik, Francisco Ojeda, Tanja Zeller, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|September 12, 2022
Temporal trends in incidence, patient characteristics, microbiology and in-hospital mortality in patients with infective endocarditis: a contemporary analysis of 86,469 cases between 2007 and 2019Peter Moritz Becher, Alina Goßling, Nina Fluschnik, et al.
Critical Care (London, England)|September 7, 2021
Seasonal trends of incidence and outcomes of cardiogenic shock : findings from a large, nationwide inpatients sample with 441,696 casesPeter Moritz Becher, Benedikt Schrage, Alina Goßling, et al.
Critical Care (London, England)|June 7, 2020
Procedural volume and outcomes in patients undergoing VA-ECMO supportPeter Moritz Becher, Alina Goßling, Benedikt Schrage, et al.
Pageof 3